Featured image for “Review of ELEHEAR Beyond Hearing Aids”
Oct. 10, 2024

Review of ELEHEAR Beyond Hearing Aids

HHTM
Since its inception in 2017, ELEHEAR has swiftly carved out a niche in the fiercely competitive direct-to-consumer hearing aid market, thanks to its pioneering use of AI technology. By harnessing advanced Computational Auditory Scene Analysis (CASA) and deep learning, ELEHEAR has powered over 200 million consumer devices worldwide. Initially, ELEHEAR operated in the OEM (Original Equipment Manufacturer) market, where it
Featured image for “Starkey Unveils Edge AI Hearing Aids, Featuring Advanced Processing and Connectivity”
Oct. 09, 2024

Starkey Unveils Edge AI Hearing Aids, Featuring Advanced Processing and Connectivity

HHTM
EDEN PRAIRIE, MINNESOTA – Starkey has announced the launch of Edge AI, its latest advancement in hearing technology designed to enhance patient care with improved performance and connectivity. Building on the success of its previous Genesis AI platform, Edge AI introduces new features such as a groundbreaking G2 Neuro Processor, deep neural network processing, and enhanced Bluetooth LE Audio capabilities.
Featured image for “The Latest Advances in Otoprotective Agents with Ting Therapeutics CEO, Dr. Jian Zuo”
Oct. 08, 2024

The Latest Advances in Otoprotective Agents with Ting Therapeutics CEO, Dr. Jian Zuo

HHTM
Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company’s innovative drug candidates and how they aim to address the unmet need for hearing protection. He provides an overview of Ting Therapeutics’ preclinical research, outlining key
Featured image for “When We Can’t Hear Our Own Voice, Even Temporarily, Our Ability to Speak is Impaired”
Oct. 07, 2024

When We Can’t Hear Our Own Voice, Even Temporarily, Our Ability to Speak is Impaired

HHTM
MONTREAL, QUEBEC — A new study from McGill University has found that the ability to hear one’s own voice is vital for maintaining coordinated speech movements, a discovery that holds significant implications for individuals with hearing loss, particularly those using cochlear implants (CIs). Published in the Journal of the Acoustical Society of America, the research highlights the essential role hearing
Featured image for “Rural vs Urban: The Growing Divide in Hearing Care Access for Older Adults”
Oct. 04, 2024

Rural vs Urban: The Growing Divide in Hearing Care Access for Older Adults

HHTM
Hearing loss among older adults in the United States has become a major public health concern in recent years. Untreated hearing loss is associated with serious issues like depression, social isolation, and cognitive decline. However, despite the availability of hearing aids, fewer than 20% of adults with hearing loss choose to use them. A new study led by Dr. Sarah
Featured image for “Amplifon Named One of America’s 200 Most Loved Workplaces by Newsweek”
Oct. 02, 2024

Amplifon Named One of America’s 200 Most Loved Workplaces by Newsweek

HHTM
MINNEAPOLIS, MINNESOTA – Amplifon, the parent company of Miracle-Ear and a global leader in hearing care services and solutions, has been recognized in Newsweek’s annual ranking of America’s 200 Most Loved Workplaces®. Amplifon is the only company in the hearing care industry to be included in this prestigious list. The ranking, developed by Newsweek in collaboration with Most Loved Workplaces®
Featured image for “Communicating Clearly and Ethically about Hearing Loss, Cognitive Decline and Dementia”
Oct. 02, 2024

Communicating Clearly and Ethically about Hearing Loss, Cognitive Decline and Dementia

HHTM
How do we communicate the link between hearing loss and cognitive decline without misleading patients? In this keynote session from the 2024 Academy of Doctors of Audiology conference, Dr. Jan Blustein dives deep into the challenge of delivering clear and ethical messages about hearing health. She addresses the common pitfalls in public health communication, such as headlines that claim “hearing
Featured image for “Starkey’s Jeff Solum Receives 2024 Working Group Leadership Award from Bluetooth”
Oct. 01, 2024

Starkey’s Jeff Solum Receives 2024 Working Group Leadership Award from Bluetooth

HHTM
EDEN PRAIRIE, MINNESOTA – Starkey has announced that Jeff Solum, Wireless Systems Architect, has been honored with the 2024 Working Group Leadership Award from Bluetooth. This award recognizes exceptional contributions and leadership in advancing Bluetooth technology within its global community of over 40,000 members. As the chair of the Bluetooth Hearing Aid Working Group, Solum has played a pivotal role
Featured image for “Justice Department Reaches Agreement with Wisconsin Prisons to Improve Access for Deaf and Hard of Hearing Inmates”
Oct. 01, 2024

Justice Department Reaches Agreement with Wisconsin Prisons to Improve Access for Deaf and Hard of Hearing Inmates

HHTM
The U.S. Department of Justice (DOJ) has reached a landmark settlement with the Wisconsin Department of Corrections (DOC) to ensure that prisoners with hearing disabilities receive the necessary accommodations while incarcerated. The agreement follows a DOJ investigation under the Americans with Disabilities Act (ADA), which revealed that the Wisconsin DOC had been failing to provide adequate support for inmates with
Featured image for “Spiral Therapeutics Reports Encouraging Phase 1b/2a Trial Results for SPT-2101 in Meniere’s Disease”
Sep. 30, 2024

Spiral Therapeutics Reports Encouraging Phase 1b/2a Trial Results for SPT-2101 in Meniere’s Disease

HHTM
SOUTH SAN FRANCISCO, CALIFORNIA — Spiral Therapeutics, Inc., a clinical-stage company focused on developing novel therapies for inner ear disorders, announced the successful completion of the Phase 1b/2a clinical trial of SPT-2101 (6% dexamethasone) in Meniere’s disease. Data review of 21 patients showed a significant reduction in vertigo frequency and severity. The study recruited 21 patients across sites in Perth,